Programmed Cell Death Tunes Tumor Immunity.

Programmed Cell Death Tunes Tumor Immunity.
复制标题

程序性细胞死亡调节肿瘤免疫。

DOI:
10.3389/fimmu.2022.847345
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Hu, Yi
Hu, Yi
中科院分区:
医学2区
文献类型:
--
作者:
Liu, Jing;Hong, Minjing;Li, Yijia;Chen, Dan;Wu, Yangzhe;Hu, Yi

文献摘要

参考文献

被引文献

相似文献

细胞以各种方式死亡,使身体能够清除不需要的细胞。多年来的研究揭示了几个关键细胞死亡途径的独特分子机制和功能后果。目前研究最多的程序性细胞死亡(PCD)包括细胞凋亡、坏死性凋亡、焦亡、铁亡、全细胞凋亡和自噬,它们在调节免疫抑制性肿瘤微环境(TME)和决定癌症治疗方法的临床结果方面起着至关重要的作用。PCD可以发挥促肿瘤或抗肿瘤的双重作用,部分取决于在此过程中释放的细胞内内容物。PCD还调节效应或调节免疫细胞的富集,从而参与微调TME中的抗肿瘤免疫。本文主要从细胞凋亡、坏死性凋亡、焦亡、铁凋亡、PAN凋亡和自噬等方面进行综述,讨论了TME中释放的分子信使参与调节其与免疫反应的复杂相互作用,并探讨了PCD的免疫学后果及其在未来癌症治疗中的意义。
The demise of cells in various ways enables the body to clear unwanted cells. Studies over the years revealed distinctive molecular mechanisms and functional consequences of several key cell death pathways. Currently, the most intensively investigated programmed cell death (PCD) includes apoptosis, necroptosis, pyroptosis, ferroptosis, PANoptosis, and autophagy, which has been discovered to play crucial roles in modulating the immunosuppressive tumor microenvironment (TME) and determining clinical outcomes of the cancer therapeutic approaches. PCD can play dual roles, either pro-tumor or anti-tumor, partly depending on the intracellular contents released during the process. PCD also regulates the enrichment of effector or regulatory immune cells, thus participating in fine-tuning the anti-tumor immunity in the TME. In this review, we focused primarily on apoptosis, necroptosis, pyroptosis, ferroptosis, PANoptosis, and autophagy, discussed the released molecular messengers participating in regulating their intricate crosstalk with the immune response in the TME, and explored the immunological consequence of PCD and its implications in future cancer therapy developments.
DOI: 10.1007/s00018-010-0413-8
发表时间: 2010-10
影响因子: 8
作者:
Challa, Sreerupa;Chan, Francis Ka-Ming
通讯作者: Chan, Francis Ka-Ming
DOI: 10.1038/s41423-020-00630-3
发表时间: 2021-05
影响因子: 24.1
作者:
Bertheloot D;Latz E;Franklin BS
通讯作者: Franklin BS
DOI: 10.3389/fonc.2012.00149
发表时间: 2012
影响因子: 4.7
作者:
Wang YS;Liu SJ;Huang SC;Chang CC;Huang YC;Fong WL;Chi MS;Chi KH
通讯作者: Chi KH
DOI: 10.1084/jem.20100050
发表时间: 2010-05-10
期刊: The Journal of experimental medicine
影响因子: --
作者:
Allen IC;TeKippe EM;Woodford RM;Uronis JM;Holl EK;Rogers AB;Herfarth HH;Jobin C;Ting JP
通讯作者: Ting JP
DOI: 10.1371/journal.pone.0065181
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Bugaut H;Bruchard M;Berger H;Derangère V;Odoul L;Euvrard R;Ladoire S;Chalmin F;Végran F;Rébé C;Apetoh L;Ghiringhelli F;Mignot G
通讯作者: Mignot G